High risk myelodysplastic syndrome
Clinical trials for High risk myelodysplastic syndrome explained in plain language.
Never miss a new study
Get alerted when new High risk myelodysplastic syndrome trials appear
Sign up with your email to follow new studies for High risk myelodysplastic syndrome, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Can an experimental pill block a cancer-driving enzyme in hard-to-treat leukemia?
Disease control Stopped earlyResearchers are testing RVU120, an experimental oral drug, in adults with acute myeloid leukemia (AML) that has come back or stopped responding to treatment, or with high-risk myelodysplastic syndrome (MDS). The drug blocks two enzymes called CDK8 and CDK19, which may play a role…
Matched conditions: HIGH RISK MYELODYSPLASTIC SYNDROME
Phase 1 • Sponsor: Ryvu Therapeutics SA • Aim: Disease control
Last updated Sep 20, 2026 00:00 UTC
-
Can a CDK8/CDK19 blocker help when leukemia and MDS return?
Disease control Stopped earlyResearchers are testing an experimental drug called RVU120 in adults with acute myeloid leukemia (AML) or high-risk myelodysplastic syndrome (MDS) that has come back or stopped responding to treatment. RVU120 blocks two proteins, CDK8 and CDK19, that may help cancer cells grow. T…
Matched conditions: HIGH RISK MYELODYSPLASTIC SYNDROME
Phase 2 • Sponsor: Ryvu Therapeutics SA • Aim: Disease control
Last updated Sep 18, 2026 00:00 UTC